Science News
from research organizations

Aging impacts epigenome in human skeletal muscle

Date:
November 20, 2013
Source:
Buck Institute for Research on Aging
Summary:
Our epigenome is a set of chemical switches that turn parts of our genome off and on and are impacted by environmental factors including diet, exercise and stress. Research reveals that aging also effects the epigenome in human skeletal muscle. The study provides a method to study sarcopenia, the degenerative loss of muscle mass that begins in middle age.
Share:
         
Total shares:  
FULL STORY

Our epigenome is a set of chemical switches that turn parts of our genome off and on at strategic times and locations. These switches help alter the way our cells act and are impacted by environmental factors including diet, exercise and stress. Research at the Buck Institute reveals that aging also effects the epigenome in human skeletal muscle. The study, appearing on line in Aging Cell, provides a method to study sarcopenia, the degenerative loss of muscle mass that begins in middle age.

The results came from the first genome-wide DNA methylation study in disease-free individuals. DNA methylation involves the addition of a methyl group to the DNA and is involved in a particular layer of epigenetic regulation and genome maintenance. In this study researchers compared DNA methylation in samples of skeletal muscle taken from healthy young (18 -- 27 years of age) and older (68 -- 89 years of age) males. Buck faculty and lead scientist Simon Melov, PhD, said researchers looked at more than 480,000 sites throughout the genome. "We identified a suite of epigenetic markers that completely separated the younger from the older individuals -- there was a change in the epigenetic fingerprint," said Melov. "Our findings were statistically significant; the chances of that happening are infinitesimal."

Melov said scientists identified about six-thousand sites throughout the genome that were differentially methylated with age and that some of those sites are associated with genes that regulate activity at the neuromuscular junction which connects the nervous system to our muscles. "It's long been suspected that atrophy at this junction is a weak link in sarcopenia, the loss of muscle mass we get with age," said Melov. "Maybe this differential methylation causes it. We don't know."

Studying the root causes and development of sarcopenia in humans is problematic; the research would require repeated muscle biopsies taken over time, something that would be hard to collect. Melov says now that the epigenetic markers have been identified in humans, the goal would be to manipulate those sites in laboratory animals. "We would be able to observe function over time and potentially use drugs to alter the rate of DNA methylation at those sites," he said. Melov says changes in DNA methylation are very common in cancer and that the process is more tightly controlled in younger people.


Story Source:

The above story is based on materials provided by Buck Institute for Research on Aging. Note: Materials may be edited for content and length.


Journal Reference:

  1. Simon Melov, PhD et al. Genome-wide DNA methylation changes with age in disease-free human skeletal muscle. Aging Cell, November 2013

Cite This Page:

Buck Institute for Research on Aging. "Aging impacts epigenome in human skeletal muscle." ScienceDaily. ScienceDaily, 20 November 2013. <www.sciencedaily.com/releases/2013/11/131120143629.htm>.
Buck Institute for Research on Aging. (2013, November 20). Aging impacts epigenome in human skeletal muscle. ScienceDaily. Retrieved May 6, 2015 from www.sciencedaily.com/releases/2013/11/131120143629.htm
Buck Institute for Research on Aging. "Aging impacts epigenome in human skeletal muscle." ScienceDaily. www.sciencedaily.com/releases/2013/11/131120143629.htm (accessed May 6, 2015).

Share This Page:


Recommended Content
 


Plants & Animals News
May 6, 2015

Latest Headlines
updated 12:56 pm ET